ATH 0.00% 0.4¢ alterity therapeutics limited

new alzheimers test, page-5

  1. 5,898 Posts.
    lightbulb Created with Sketch. 151
    Yes Alois, I guess it is, but the idea goes back way before 2007.Check this link.
    http://resources.metapress.com/pdf-preview.axd?code=b1603j5q4p532t53&size=largest
    What the Japanese scientists have done is develop an assay test to check levels of AB in the CSF(cerebrospinal fluid)and verified its accuracy against progressing alzheimers patients. AB in the CSF increases as the disease progresses.

    "We hope that our new diagnostic test will, in the future, significantly improve the lives of people with Alzheimer's disease, and lead to much better ways of treating this devastating disorder."

    As for Prana
    . PBT2 has completed a PHASE 2A STUDY in Alzheimer痴 Disease patients, demonstrating a lowering of Abeta levels in the CSF and signs of cognitive improvement within three months.

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 10000 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 50000 1
View Market Depth
Last trade - 09.32am 30/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.